Latest News
Feature
Massive databases unleash discovery, but not so much in the U.S.
Vast medical databases have connected dots where smaller randomized trials could not. But the United States has a long way to go.
Conference Coverage
Bariatric surgery, including sleeve gastrectomy, linked to fracture risk
A study of a largely male veteran population reinforces observations in younger women and underscores concerns about osteoporosis in men.
Conference Coverage
Tricyclics may raise fracture risk in type 2 diabetes
Although the findings are suggestive, they don’t definitively pin blame on tricyclic antidepressants alone in directly leading to fractures.
Feature
Psoriatic disease: Researchers seek a PsA diagnostic test, phenotype-targeted treatment
Researchers described ongoing work to “understand the discrete and overlapping endotypes that underlie the phenotypes” of psoriatic disease and to...
Feature
Employment vs. private practice: Who’s happier?
“It used to be that fewer hospitals offered employment, so private practice was the way to go. Now, there are fewer privates because hospitals and...
Conference Coverage
New calculator tool estimates fracture risk on dialysis
Calculator uses readily available clinical factors and will soon be freely accessible.
Conference Coverage
Treatment order evidence comes to light for premenopausal idiopathic osteoporosis: What to do after denosumab
Extension trial gives insight into treatment order for a little-studied population of premenopausal women.
Feature
Researchers link two genes to Raynaud’s disease
The discovery will hopefully lead to new therapeutic avenues for the condition, experts say.
Conference Coverage
Higher fracture risk not seen with SGLT2 inhibitors
Increased fracture risk seen in short-term studies may have been caused by hypovolemia or osmotic diuresis, resulting in falls, rather than an...
Latest News
FDA approves bimekizumab for moderate to severe plaque psoriasis in adults
With this approval, bimekizumab becomes the only interleukin (IL)-17A and IL-17F inhibitor approved for the treatment of these patients.
Latest News
Pilot study: High-dose IL-23 inhibition shows promise for psoriasis remission in some patients
Targeting resident memory T cells may be a key to long-term remission.